Setrusumab (BPS 804) is a fully humanized monoclonal antibody targets sclerostin. Setrusumab efftively improves bone strength. Setrusumab can be used for the resesrch of Osteogenesis Imperfecta (OI) and cancer.
CAS Number:
[1847394-95-9]
Target:
Others
* VAT and and shipping costs not included. Errors and price changes excepted